1. Home
  2. TIL vs MPTI Comparison

TIL vs MPTI Comparison

Compare TIL & MPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • MPTI
  • Stock Information
  • Founded
  • TIL 2018
  • MPTI 1965
  • Country
  • TIL United States
  • MPTI United States
  • Employees
  • TIL N/A
  • MPTI N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • MPTI
  • Sector
  • TIL Health Care
  • MPTI
  • Exchange
  • TIL Nasdaq
  • MPTI Nasdaq
  • Market Cap
  • TIL 171.7M
  • MPTI 147.2M
  • IPO Year
  • TIL 2021
  • MPTI N/A
  • Fundamental
  • Price
  • TIL $13.23
  • MPTI $56.61
  • Analyst Decision
  • TIL Buy
  • MPTI
  • Analyst Count
  • TIL 5
  • MPTI 0
  • Target Price
  • TIL $114.00
  • MPTI N/A
  • AVG Volume (30 Days)
  • TIL 180.4K
  • MPTI 38.6K
  • Earning Date
  • TIL 05-20-2025
  • MPTI 05-13-2025
  • Dividend Yield
  • TIL N/A
  • MPTI N/A
  • EPS Growth
  • TIL N/A
  • MPTI 107.03
  • EPS
  • TIL N/A
  • MPTI 2.65
  • Revenue
  • TIL N/A
  • MPTI $49,012,000.00
  • Revenue This Year
  • TIL N/A
  • MPTI $11.76
  • Revenue Next Year
  • TIL N/A
  • MPTI $7.64
  • P/E Ratio
  • TIL N/A
  • MPTI $21.26
  • Revenue Growth
  • TIL N/A
  • MPTI 19.05
  • 52 Week Low
  • TIL $9.62
  • MPTI $26.99
  • 52 Week High
  • TIL $92.00
  • MPTI $71.10
  • Technical
  • Relative Strength Index (RSI)
  • TIL 44.22
  • MPTI 59.17
  • Support Level
  • TIL $11.97
  • MPTI $51.10
  • Resistance Level
  • TIL $14.67
  • MPTI $58.06
  • Average True Range (ATR)
  • TIL 2.05
  • MPTI 3.53
  • MACD
  • TIL -0.04
  • MPTI -0.23
  • Stochastic Oscillator
  • TIL 17.87
  • MPTI 68.17

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.

Share on Social Networks: